Efficacy and safety of stereotactic radiotherapy in patients with HER2-positive breast cancer brain metastases following intracranial oligoprogression

• by Dongxing, Shen , Longyu, Zhu , Jun, Zhang , Deyou, Kong , Zhikun, Liu

• May 31, 2026

Age-related prognoses in a Luxembourgish breast cancer cohort

• by Allini Mafra, Sophie Couffignal, René Aloisio da Costa Vieira, Caroline Duhem, Claudine Backes

• June 22, 2026

Stereotactic versus whole-brain radiotherapy combined with immunotherapy in driver gene–negative NSCLC with brain metastases: a real-world IPTW analysis

• by Erha Munai, Lisi Sun, Amu Jike, Dan Tao, Nan Li, Jiang He, Yu He, Liang Du, Wei Zhou, Yongzhong Wu, Dingyi Yang

• June 22, 2026

Virtual Staining and the Next Era of Pathology

How AI enables scalable biomarker analysis that preserves tissue samples, addressing some of the most persistent bottlenecks in clinical care and research

• by Kenneth To

• June 19, 2026

• 6 min